Zephyrm Biotech Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • IPO Registration

  • Employees
  • 97

Employees

  • Latest Deal Type
  • IPO
  • (Announced)

  • Investors
  • 14

Zephyrm Biotech General Information

Description

Developer and producer of stem cell drugs focusing on PSC-derived cell therapy. The company develops stem cell drugs with independent intellectual property rights, and promotes the clinical application and industrial transformation of stem cells, enabling clients to meet the needs that cannot be satisfied by current traditional medicines and treatment methods.

Contact Information

Website
www.zephyrm.com
Ownership Status
In IPO Registration
Financing Status
Venture Capital-Backed
Corporate Office
  • Floor 6, Block A, Pangu Daguan Office Building
  • No. 27 North Fourth Ring Middle Road, Chaoyang District
  • Beijing
  • China
+86 010
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Floor 6, Block A, Pangu Daguan Office Building
  • No. 27 North Fourth Ring Middle Road, Chaoyang District
  • Beijing
  • China
+86 010

Zephyrm Biotech Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zephyrm Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. IPO 01-Oct-2024 Announced Clinical Trials - General
6. Secondary Transaction - Private 22-Mar-2024 Completed Clinical Trials - General
5. Early Stage VC (Series B2) 25-Apr-2024 Completed Clinical Trials - General
4. Early Stage VC (Series B1) 27-Dec-2023 Completed Clinical Trials - General
3. Early Stage VC (Series B) 12-Dec-2022 Completed Clinical Trials - General
2. Early Stage VC (Series A) 14-Apr-2021 $24.4M $45.8M Completed Clinical Trials - General
1. Early Stage VC 27-Dec-2019 $21.4M $21.4M Completed Clinical Trials - General
To view Zephyrm Biotech’s complete valuation and funding history, request access »

Zephyrm Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Zephyrm Biotech Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Beijing Huairou Science City Technology Services Corporation Minority
Guangdong Technology Financial Group Government Minority
Zhongshan Financial Investment Venture Capital Minority
Zhongshan Health Base Group Government Minority
Zhongshan Torch Electronic Industry Fund Management Venture Capital Minority
You’re viewing 5 of 14 investors. Get the full list »

Zephyrm Biotech FAQs

  • When was Zephyrm Biotech founded?

    Zephyrm Biotech was founded in 2018.

  • Where is Zephyrm Biotech headquartered?

    Zephyrm Biotech is headquartered in Beijing, China.

  • What is the size of Zephyrm Biotech?

    Zephyrm Biotech has 97 total employees.

  • What industry is Zephyrm Biotech in?

    Zephyrm Biotech’s primary industry is Drug Discovery.

  • Is Zephyrm Biotech a private or public company?

    Zephyrm Biotech is a Private company.

  • What is Zephyrm Biotech’s current revenue?

    The current revenue for Zephyrm Biotech is .

  • How much funding has Zephyrm Biotech raised over time?

    Zephyrm Biotech has raised $89.1M.

  • Who are Zephyrm Biotech’s investors?

    Beijing Huairou Science City Technology Services, Guangdong Technology Financial Group, Zhongshan Financial Investment, Zhongshan Health Base Group, and Zhongshan Torch Electronic Industry Fund Management are 5 of 14 investors who have invested in Zephyrm Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process